What MyCareGorithm does

MyCareGorithm, LLC is a U.S.-based private digital health company founded in 2021 and headquartered in Watchung, New Jersey, that builds a cloud-based visual consultation platform exclusively for oncology. The platform translates complex cancer diagnoses, staging, and treatment pathways into 3D models, annotated graphics, animated treatment pathways, and structured dashboards intended to be used inside the 10–15 minute consultation window. Its content library comprises 19 disease-specific modules covering 23 cancer types — including prostate, breast, lung, thyroid, pancreatic, colorectal, brain, melanoma, myeloma, and sarcoma — co-developed with oncology specialists and aligned to clinical guidelines. It also offers take-home resources and EHR integration, and a Diagnosis & Staging Module for myeloma built with the Leukemia & Lymphoma Society.

The company's primary customers are U.S. healthcare institutions — cancer centers, hospitals, and oncology practices — reached through an enterprise field sales motion supplemented by conference presence at events such as Astro 2025, the World Conference on Thyroid Cancer, and CMCN 2025. Pilots and case studies have been published with Moffitt Cancer Center, Mount Sinai Tisch Cancer Center, University of Virginia Cancer Center, and NYU Perlmutter Cancer Center, reporting 95–97% patient understanding improvement, 96% recommendation rates, and 100% provider willingness to integrate. MyCareGorithm generates revenue through a quote-based multi-year SaaS subscription model targeting institutions and oncology practices, with no public price list disclosed. The company reports 11–50 employees, no disclosed external funding beyond its participation in the CancerX Startup Accelerator (2026), and physician leadership under CEO and Co-Founder Louis Harrison, MD, FASTRO.

Name

MyCareGorithm

Legal name

MyCareGorithm, LLC

Website

https://mycaregorithm.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

MyCareGorithm is a physician-led U.S. digital health company that sells a cloud-based, EHR-integrated oncology consultation platform with 19 visual modules spanning 23 cancer types to U.S. cancer centers, hospitals, and oncology practices via multi-year enterprise SaaS subscriptions.

Ownership category

akta.pro rank

Product category

Oncology Clinical Software

NAICS

Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000)

akta.pro primary industry

Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)

Keywords

• Oncology consultation software
• Visual patient education
• Cancer treatment visualization
• Clinical decision support
• Patient engagement platform

Headquarters

HQ city

Watchung

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscription: Cloud-based platform subscription model for healthcare institutions, oncology practices, and cancer centers. Pricing is quote-based with no public price list disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

MyCareGorithm provides a cloud-based visual consultation platform for oncology that translates complex cancer information into 3D anatomical models, annotated clinical graphics, and animated treatment pathway visualizations. The platform equips oncologists with disease-specific modules covering 23 cancer types, structured consultation workflows, EHR integration, and personalized take-home patient resources to improve comprehension and informed consent.

Product overview

MyCareGorithm is a cloud-based digital consultation platform for oncology care. The core platform provides visual learning tools, a structured dashboard, and multimedia content library to enhance doctor-patient communication during cancer consultations. The product portfolio consists of 19 disease-specific modules covering 23 cancer types: Anal Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Cervix/Uterus Cancer, Colon Cancer, Kidney Cancer, Larynx/Oral Cavity Cancer, Lung Cancer, Melanoma, Myeloma, Oropharynx/Nasopharynx Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Stomach/Esophagus Cancer, and Thyroid Cancer. These modules provide visual treatment pathways, staging explanations, and comparative treatment option displays. The platform also includes Take-Home Resources that allow patients to access personalized summaries after consultations. The system integrates with EHR systems for real-time patient data access.

Differentiator

Problem solved

Functional benefit

Products and services

• MyCareGorithm Platform Cloud-based SaaS platform that equips oncologists with 3D anatomical models, annotated clinical graphics, animated treatment pathway visualizations, EHR integration, a structured consultation dashboard, AI-supported knowledge retrieval, and personalized patient take-home resources. Designed for cancer centers, hospitals, and oncology practices.
• Disease-Specific Cancer Modules (19 modules covering 23 cancer types) Curated set of 19 disease-specific modules covering 23 cancer types, providing oncologists with pre-built visual content for breast cancer, head and neck cancer, lung cancer, gastrointestinal cancers, gynecologic cancers, genitourinary cancers, hematologic malignancies, melanoma, sarcoma, pediatric cancers, and others. Each module includes 3D models, annotated graphics, and animated treatment pathways.

Quantifiable outcome

• 95% of patients noted visual tools enhanced their understanding of their disease
• +11 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core and supporting.

• THANC (Thyroid, Head and Neck Cancer) FoundationcoreStrategic or Co-development Partner · 5 February 2026MyCareGalgorithm, LLC and the THANC Foundation partnered to redefine the standard of care for more than 50,000 Americans and over 300,000 patients worldwide undergoing consultation for newly diagnosed thyroid cancer. The collaboration brings novel visual learning tools to the doctor-patient interaction. Cloud-based tools transform the consultation into a multimedia experience allowing patients to understand options for care, make informed decisions, and accomplish these goals with comprehensiveness, confidence, and efficiency. Dr. Mark Urken, Professor and former chairman of the Department of Otolaryngology Head and Neck Surgery at Icahn School of Medicine at Mount Sinai and Founder/Medical Advisor to THANC Foundation, provided expert endorsement of the thyroid module.
• Moffitt Cancer CentercoreStrategic or Co-development PartnerConducted a case study with 20 localized pancreatic cancer patients aged 54-89 years. The study analyzed how a visual consultation tool influenced understanding of diagnosis and treatment. Results showed 88% of patients strongly agreed the tool impacted understanding of disease and treatment plan, and 100% strongly agreed it enhanced their confidence in the provider's care.
• Mount Sinai Tisch Cancer CentercoreStrategic or Co-development PartnerConducted a pilot study assessing the impact of digital visual tools on 32 English-speaking breast cancer patients' understanding of their disease and treatment recommendations during initial radiation oncology consultation. Study demonstrated enhanced patient understanding and improved clinical team engagement quality.
• University of Virginia Cancer CentercoreStrategic or Co-development PartnerIRB-approved study evaluating the effectiveness of the digital health tool for both patients and physicians. 31 patients, 12 companions, and 2 physicians completed surveys to evaluate their experience.
• NYU Perlmutter Cancer CentercoreStrategic or Co-development PartnerIRB-approved study with patients and caregivers receiving head and neck cancer radiation. Patients underwent initial consultation using the digital tool and completed surveys to evaluate their understanding of their disease.
• Leukemia & Lymphoma Society (LLS)supportingStrategic or Co-development PartnerMyCareGalgorithm's Diagnosis & Staging Module for myeloma was developed in collaboration with the Leukemia & Lymphoma Society (LLS), guiding oncologists through a step-by-step visual narrative including real-time annotations on patient-specific scans, simplified explanations of antibody chains, M-protein formation, and myeloma staging criteria.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• BioDigital: Cloud-based interactive 3D human anatomy and medical visualization platform used for patient education and clinical training. Comparable to MyCareGorithm's 3D model and animation capabilities, with overlapping use cases in explaining diagnoses through visualization, though not oncology-specialized.

Broad incumbents

• Outcome Health: Provider of point-of-care health education content delivered via digital screens and tablets in physician offices, including specialty practices. Overlaps with MyCareGorithm's in-exam-room visual education mission but at a broader primary-care and multi-specialty footprint.
• PatientPoint: Largest point-of-care patient education and engagement platform in US physician offices and health systems. Comparable as a broader patient education incumbent with established hospital relationships, though its content is less oncology-specialized than MyCareGorithm's.
• Krames (Staywell): Long-established patient education and consumer health content provider widely integrated into EHRs and hospital systems. Comparable as the legacy default for written/visual patient education that MyCareGorithm positions against with its oncology-specialized 3D consultation workflow.
• Phreesia: Public, scaled patient intake and engagement platform deployed across thousands of provider organizations with deep EHR integrations. Comparable as a healthcare SaaS incumbent that hospitals may already pay for, presenting both competitive overlap and a channel partnership opportunity for oncology content.
• Healthwise: Major patient education content vendor whose evidence-based materials are licensed by health systems and EHRs. Comparable as a substitute supplier of patient education content for hospitals; oncology-specific 3D visualization differentiates MyCareGorithm from Healthwise's mostly text-and-video library.
• GetWellNetwork: Incumbent patient engagement platform used by hundreds of hospitals to deliver education, discharge planning, and interactive patient experiences. Comparable as a broader enterprise patient engagement incumbent that MyCareGorithm would need to displace or partner with inside oncology service lines.

Direct peers

• Noona: Patient-reported outcomes and engagement platform deployed by oncology practices to capture symptoms, deliver education, and support remote monitoring. Comparable to MyCareGorithm in that both serve cancer centers with structured patient education and engagement tools integrated into the consultation workflow.
• Carevive: Oncology-specific patient management platform providing personalized care plans, symptom management, and remote patient monitoring. Overlaps with MyCareGorithm in delivering oncology-tailored patient education and post-consultation engagement, with comparable EHR integration requirements.
• ClinicalPath (formerly Via Oncology): Elsevier-owned oncology clinical decision support and pathways platform used by cancer centers to standardize treatment decisions. Directly comparable to MyCareGorithm's oncology decision support and care pathway visualization focus, though it is structured around evidence-based pathway selection rather than patient-facing visual consultation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mycaregorithm

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyCareGorithm